Get started
Author

Tomoki Nakajima

Observed names: T Nakajima, T. Nakajima, TOMOKI NAKAJIMA, Tomoki NAKAJIMA
ORCID: 0009-0003-7733-0921
Observed ORCID: 0009-0003-7733-0921
OpenAlex ID: A5110338221
A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins
2005 · T. Nishikawa, T. Nakajima, et al. · Journal of Hepatology · 182
Fenofibrate, a peroxisome proliferator‐activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver
2006 · Yuichi Harano, Kohichiroh Yasui, et al. · Liver International · 149
Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry
1998 · Hiroyuki Kimura, Tomoki Nakajima, et al. · Liver International · 116
The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin‐8 production
2002 · Michihisa Moriguchi, Tomoki Nakajima, et al. · International Journal of Cancer · 96
Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis
2005 · Masahito Minami, Yukiko Daimon, et al. · Oncogene · 91
High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells
2011 · Chihiro Yokomizo, Kanji Yamaguchi, et al. · Cancer Letters · 84
A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase
2005 · Takeshi Okanoue, Akiko Makiyama, et al. · Journal of Hepatology · 77
Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD
2005 · Tomoki Nakajima, Michihisa Moriguchi, et al. · Liver International · 73
Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma
2019 · AYA TAKAHASHI, MICHIHISA MORIGUCHI, et al. · Anticancer Research · 71
Role of cell‐cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C
2006 · Satoru Sekoguchi, Tomoki Nakajima, et al. · Journal of Gastroenterology and Hepatology · 68
Rosuvastatin ameliorates high‐fat and high‐cholesterol diet‐induced nonalcoholic steatohepatitis in rats
2012 · Yoshihisa Okada, Kanji Yamaguchi, et al. · Liver International · 64
Nuclear size measurement is a simple method for the assessment of hepatocellular aging in non-alcoholic fatty liver disease: Comparison with telomere-specific quantitative FISH and p21 immunohistochemistry
2010 · Tomoki Nakajima, Toshiaki Nakashima, et al. · Pathology International · 60
Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma
2007 · Atsushi Umemura, Yoshito Itoh, et al. · Hepatology · 56
PDF
Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma
2011 · Masayasu Jo, Taichiro Nishikawa, et al. · Journal of Gastroenterology · 55
Chemokine CCL20 enhances the growth of HuH7 cells via phosphorylation of p44/42 MAPK in vitro
2004 · Hideki Fujii, Yoshito Itoh, et al. · Biochemical and Biophysical Research Communications · 41
Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation
2009 · Taichiro Nishikawa, Tomoki Nakajima, et al. · Liver International · 40
Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma
2004 · Tomoki Nakajima, Michihisa Moriguchi, et al. · Modern Pathology · 40
PDF
Simple tumor profile chart based on cell kinetic parameters and histologic grade is useful for estimating the natural growth rate of hepatocellular carcinoma
2002 · Tomoki Nakajima, Michihisa Moriguchi, et al. · Human Pathology · 32
Intrahepatic Splenosis with Severe Iron Deposition Presenting with Atypical Magnetic Resonance Images
2008 · Tomoki Nakajima, Atsushi Fujiwara, et al. · Internal Medicine · 30
PDF
In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma
2005 · Hidetaka Takashima, Tomoki Nakajima, et al. · Liver International · 30
Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis
2020 · Aya Takahashi, Michihisa Moriguchi, et al. · Cancers · 25
PDF
Cytogenetic analyses of hepatocellular carcinoma by in situ hybridization with a chromosome-specific DNA probe
1996 · Hiroyuki Kimura, Keizo Kagawa, et al. · Cancer · 20
Evaluation of hepatic proliferative activity in chronic liver diseases and hepatocellular carcinomas by proliferating cell nuclear antigen (PCNA) immunohistochemical staining of methanol-fixed tissues
1994 · Tomoki Nakajima, Keizo Kagawa, et al. · Journal of Gastroenterology · 20
Successful Treatment of a Previously Healthy Woman with Pseudomonas aeruginosa Community-acquired Pneumonia with Plasmapheresis
2012 · Masashi Okamoto, Junko Yamaoka, et al. · Internal Medicine · 16
PDF
Loss of p53 transcriptional activity in hepatocellular carcinoma evaluated by yeast-based functional assay: comparison with p53 immunohistochemistry
2004 · Yasuhide Mitsumoto, Tomoki Nakajima, et al. · Human Pathology · 14
Works count: 54
Citation count: 1,686
H-index: 21
I10-index: 32
Year
Topic
Type